Data analysis reveals treatment trends for menopause symptoms, indicating the need for safer alternatives.
While the number of patients who received HT constituted approximately 1% of the estimated 9.31 million menopausal population in South Korea, most patients prescribed HT had a medical condition of interest at baseline that was a contraindication or precaution for HT. There is a need to identify additional well-tolerated, effective alternatives.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: